A Phase 1/2a Clinical Trial to Evaluate the Efficacy and Safety of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cell Clusters in Patients with Critical Limb Ischemia.

Int J Stem Cells · 2025 · PMC12394084 · PMID 40091311

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

An increasing trend was maintained from baseline through 4, 12, and 24 weeks, suggesting an improvement in limb ischemia following ADMSCCs administration ( Fig. 2 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.